Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTalis Biomedical Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$6.99 | -$6.99 | -$6.99 |
| Q2 2025 | 1 | -$7.03 | -$7.03 | -$7.03 |
| Q3 2025 | 1 | -$7.33 | -$7.33 | -$7.33 |
| Q4 2025 | 1 | -$6.43 | -$6.43 | -$6.43 |
Talis Biomedical Corporation Earnings Date And Information
Talis Biomedical Corporation last posted its earnings results on Monday, August 19th, 2024. The company reported $-4.86 earnings per share for the quarter, topping analysts' consensus estimates of $-5.914 by $1.054. The company had revenue of 0 for the quarter and had revenue of 412,000 for the year. Talis Biomedical Corporation has generated $-34 earnings per share over the last year ($-34.12 diluted earnings per share) and currently has a price-to-earnings ratio of -0.06. Talis Biomedical Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, January 6th, 2025 based on prior year's report dates.
Talis Biomedical Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/19/2024 | Q2 2024 | -$5.91 | -$4.86 | 1.05 | $0 | $0 |
| 05/08/2024 | Q1 2024 | -$6.58 | -$7.15 | -0.57 | N/A | $73,000 |
| 03/28/2024 | Q4 2023 | -$6.68 | -$7.40 | -0.72 | N/A | $151,000 |
| 09/29/2023 | Q3 2023 | N/A | -$8.62 | N/A | $105,000 | $76,000 |
| 08/10/2023 | Q2 2023 | -$0.73 | -$8.27 | -7.54 | $105,000 | $48,000 |
| 05/11/2023 | Q1 2023 | -$0.73 | -$9.32 | -8.59 | N/A | $137,000 |
| 03/22/2023 | Q4 2022 | -$11.39 | -$15.07 | -3.68 | N/A | $107,000 |
| 11/03/2022 | Q3 2022 | -$11.09 | -$14.22 | -3.13 | $360,000 | $730,000 |
| 08/02/2022 | Q2 2022 | -$12.29 | -$15.07 | -2.78 | $1.20 M | $502,000 |
| 05/10/2022 | Q1 2022 | -$17.09 | -$18.78 | -1.69 | N/A | $2.31 M |
| 03/15/2022 | Q4 2021 | -$1.28 | -$16.28 | -15 | N/A | $-218 |
| 11/15/2021 | Q3 2021 | N/A | -$22.35 | N/A | $1.46 M | $218 |
| 08/10/2021 | Q2 2021 | -$13.04 | -$37.71 | -24.67 | N/A | $0 |
| 05/13/2021 | Q1 2021 | N/A | -$69.21 | N/A | N/A | $0 |
| 03/30/2021 | Q4 2020 | N/A | -$33.69 | N/A | N/A | $10,938 |
| 09/29/2020 | Q3 2020 | N/A | -$101.53 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$34.56 | N/A | N/A | $0 |
| 03/30/2020 | Q1 2020 | N/A | -$25.37 | N/A | N/A | $0 |
| 12/30/2019 | Q4 2019 | N/A | -$26.27 | N/A | N/A | $1.51 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Talis Biomedical Corporation Earnings: FAQ's
Talis Biomedical Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, January 6th, 2025 based offlast year's report dates.
In the previous quarter, Talis Biomedical Corporation (:TLIS) reported $-4.86 earnings per share (EPS) to beat the analysts' consensus estimate of $-5.914 by $1.054.
The conference call for Talis Biomedical Corporation's latest earnings report can be listened to online.
The conference call transcript for Talis Biomedical Corporation's latest earnings report can be read online.
Talis Biomedical Corporation (:TLIS) has a recorded annual revenue of $412,000.
Talis Biomedical Corporation (:TLIS) has a recorded net income of $-62,007,000.Talis Biomedical Corporation has generated $-34.12 earnings per share over the last four quarters.
Talis Biomedical Corporation (:TLIS) has a price-to-earnings ratio of -0.06 and price/earnings-to-growth ratio is -0.01.